 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/08/2026 |
$4.11 |
$4.24 |
$3.91 |
$4.03 |
536.20K | | 06/09/2026 |
$4.06 |
$4.11 |
$3.91 |
$4.08 |
803.70K | | 06/10/2026 |
$4.06 |
$4.17 |
$3.83 |
$3.89 |
818.90K | | 06/11/2026 |
$3.90 |
$3.98 |
$3.84 |
$3.91 |
553.70K | | 06/12/2026 |
$3.94 |
$4.17 |
$3.92 |
$4.04 |
689.90K |
 |
| Ocuphire Pharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Co.'s lead retinal product candidate, APX3330, is a small-molecule inhibitor of Ref-1 (reduction oxidation effector factor-1 protein). Ref1 is a regulator of transcription factors such as HIF-1? and NF-B. The Inhibiting REF-1 reduces levels of vascular endothelial growth factor (VEGF) and inflammatory cytokines which are known to play key roles in ocular angiogenesis and inflammation. APX3330 is an oral tablet to be administered twice per day for the treatment of DR. | |
 |

Opus Genetics (IRD) has the following price history information. Looking back at IRD historical stock prices for the last five trading days, on June 08, 2026, IRD opened at $4.11, traded as high as $4.24 and as low as $3.91, and closed at $4.03. Trading volume was a total of 536.20K shares. On June 09, 2026, IRD opened at $4.06, traded as high as $4.11 and as low as $3.91, and closed at $4.08. Trading volume was a total of 803.70K shares. On June 10, 2026, IRD opened at $4.06, traded as high as $4.17 and as low as $3.83, and closed at $3.89. Trading volume was a total of 818.90K shares. On June 11, 2026, IRD opened at $3.90, traded as high as $3.98 and as low as $3.84, and closed at $3.91. Trading volume was a total of 553.70K shares. On June 12, 2026, IRD opened at $3.94, traded as high as $4.17 and as low as $3.92, and closed at $4.04. Trading volume was a total of 689.90K shares.
IRD Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Opus Genetics shares, starting with a $10,000 purchase of IRD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/16/2016 |
|
| End date: |
06/12/2026 |
|
| Start price/share: |
$0.26 |
|
| End price/share: |
$4.04 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,453.85% |
|
| Average Annual Total Return: |
31.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$155,326.56 |
|
| Years: |
9.99 |
|
|
 |
| Date |
Close |
| 06/08/2026 | $4.03 | | 06/09/2026 | $4.08 | | 06/10/2026 | $3.89 | | 06/11/2026 | $3.91 | | 06/12/2026 | $4.04 |
|
 |